nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—ALB—chronic obstructive pulmonary disease	0.437	1	CbGaD
Repaglinide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0748	0.237	CbGbCtD
Repaglinide—ALB—Prednisone—chronic obstructive pulmonary disease	0.0537	0.17	CbGbCtD
Repaglinide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0528	0.167	CbGbCtD
Repaglinide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0357	0.113	CbGbCtD
Repaglinide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0341	0.108	CbGbCtD
Repaglinide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0304	0.096	CbGbCtD
Repaglinide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0178	0.0563	CbGbCtD
Repaglinide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0168	0.0532	CbGbCtD
Repaglinide—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000975	0.0054	CcSEcCtD
Repaglinide—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000975	0.0054	CcSEcCtD
Repaglinide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000974	0.0054	CcSEcCtD
Repaglinide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000972	0.00538	CcSEcCtD
Repaglinide—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000969	0.00537	CcSEcCtD
Repaglinide—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000955	0.00529	CcSEcCtD
Repaglinide—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000953	0.00528	CcSEcCtD
Repaglinide—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000943	0.00522	CcSEcCtD
Repaglinide—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00094	0.00521	CcSEcCtD
Repaglinide—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000933	0.00517	CcSEcCtD
Repaglinide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000929	0.00515	CcSEcCtD
Repaglinide—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000921	0.0051	CcSEcCtD
Repaglinide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000915	0.00507	CcSEcCtD
Repaglinide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000915	0.00507	CcSEcCtD
Repaglinide—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000909	0.00503	CcSEcCtD
Repaglinide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000903	0.005	CcSEcCtD
Repaglinide—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000899	0.00498	CcSEcCtD
Repaglinide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000898	0.00498	CcSEcCtD
Repaglinide—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000897	0.00497	CcSEcCtD
Repaglinide—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000891	0.00494	CcSEcCtD
Repaglinide—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000891	0.00494	CcSEcCtD
Repaglinide—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000886	0.00491	CcSEcCtD
Repaglinide—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000886	0.00491	CcSEcCtD
Repaglinide—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000879	0.00487	CcSEcCtD
Repaglinide—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.000879	0.00487	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000878	0.00487	CcSEcCtD
Repaglinide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000876	0.00485	CcSEcCtD
Repaglinide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00479	CcSEcCtD
Repaglinide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000863	0.00478	CcSEcCtD
Repaglinide—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000848	0.0047	CcSEcCtD
Repaglinide—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.0047	CcSEcCtD
Repaglinide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.00469	CcSEcCtD
Repaglinide—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000838	0.00464	CcSEcCtD
Repaglinide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000837	0.00464	CcSEcCtD
Repaglinide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.00461	CcSEcCtD
Repaglinide—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000831	0.0046	CcSEcCtD
Repaglinide—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.0046	CcSEcCtD
Repaglinide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000821	0.00455	CcSEcCtD
Repaglinide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.00451	CcSEcCtD
Repaglinide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000814	0.00451	CcSEcCtD
Repaglinide—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00444	CcSEcCtD
Repaglinide—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00443	CcSEcCtD
Repaglinide—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00443	CcSEcCtD
Repaglinide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000797	0.00442	CcSEcCtD
Repaglinide—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000795	0.00441	CcSEcCtD
Repaglinide—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000782	0.00433	CcSEcCtD
Repaglinide—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000782	0.00433	CcSEcCtD
Repaglinide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000777	0.00431	CcSEcCtD
Repaglinide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000774	0.00429	CcSEcCtD
Repaglinide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000768	0.00426	CcSEcCtD
Repaglinide—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000758	0.0042	CcSEcCtD
Repaglinide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000756	0.00419	CcSEcCtD
Repaglinide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000753	0.00417	CcSEcCtD
Repaglinide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000753	0.00417	CcSEcCtD
Repaglinide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000752	0.00417	CcSEcCtD
Repaglinide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00413	CcSEcCtD
Repaglinide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00413	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00074	0.0041	CcSEcCtD
Repaglinide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000738	0.00409	CcSEcCtD
Repaglinide—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00406	CcSEcCtD
Repaglinide—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00406	CcSEcCtD
Repaglinide—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00402	CcSEcCtD
Repaglinide—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00402	CcSEcCtD
Repaglinide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000722	0.004	CcSEcCtD
Repaglinide—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00398	CcSEcCtD
Repaglinide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000716	0.00397	CcSEcCtD
Repaglinide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000716	0.00397	CcSEcCtD
Repaglinide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000715	0.00396	CcSEcCtD
Repaglinide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.00394	CcSEcCtD
Repaglinide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000711	0.00394	CcSEcCtD
Repaglinide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000707	0.00392	CcSEcCtD
Repaglinide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000707	0.00392	CcSEcCtD
Repaglinide—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000701	0.00388	CcSEcCtD
Repaglinide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000694	0.00385	CcSEcCtD
Repaglinide—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00384	CcSEcCtD
Repaglinide—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00379	CcSEcCtD
Repaglinide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000684	0.00379	CcSEcCtD
Repaglinide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.00379	CcSEcCtD
Repaglinide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000675	0.00374	CcSEcCtD
Repaglinide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000671	0.00372	CcSEcCtD
Repaglinide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000667	0.0037	CcSEcCtD
Repaglinide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000667	0.0037	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000657	0.00364	CcSEcCtD
Repaglinide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000652	0.00361	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000651	0.00361	CcSEcCtD
Repaglinide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00358	CcSEcCtD
Repaglinide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00356	CcSEcCtD
Repaglinide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00349	CcSEcCtD
Repaglinide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00346	CcSEcCtD
Repaglinide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00346	CcSEcCtD
Repaglinide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00062	0.00343	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000617	0.00342	CcSEcCtD
Repaglinide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000612	0.00339	CcSEcCtD
Repaglinide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000611	0.00339	CcSEcCtD
Repaglinide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00338	CcSEcCtD
Repaglinide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00338	CcSEcCtD
Repaglinide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000602	0.00334	CcSEcCtD
Repaglinide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.00333	CcSEcCtD
Repaglinide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.00333	CcSEcCtD
Repaglinide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000602	0.00333	CcSEcCtD
Repaglinide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000602	0.00333	CcSEcCtD
Repaglinide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000599	0.00332	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00331	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00331	CcSEcCtD
Repaglinide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00059	0.00327	CcSEcCtD
Repaglinide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00327	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000585	0.00324	CcSEcCtD
Repaglinide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000584	0.00324	CcSEcCtD
Repaglinide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.0032	CcSEcCtD
Repaglinide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.0032	CcSEcCtD
Repaglinide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000577	0.0032	CcSEcCtD
Repaglinide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000577	0.0032	CcSEcCtD
Repaglinide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00319	CcSEcCtD
Repaglinide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00315	CcSEcCtD
Repaglinide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00315	CcSEcCtD
Repaglinide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000568	0.00315	CcSEcCtD
Repaglinide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00313	CcSEcCtD
Repaglinide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00313	CcSEcCtD
Repaglinide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00313	CcSEcCtD
Repaglinide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00056	0.0031	CcSEcCtD
Repaglinide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.0031	CcSEcCtD
Repaglinide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000558	0.00309	CcSEcCtD
Repaglinide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000553	0.00306	CcSEcCtD
Repaglinide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00304	CcSEcCtD
Repaglinide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00302	CcSEcCtD
Repaglinide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00302	CcSEcCtD
Repaglinide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000538	0.00298	CcSEcCtD
Repaglinide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.00297	CcSEcCtD
Repaglinide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00293	CcSEcCtD
Repaglinide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00292	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000525	0.00291	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000525	0.00291	CcSEcCtD
Repaglinide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000518	0.00287	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000515	0.00285	CcSEcCtD
Repaglinide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000509	0.00282	CcSEcCtD
Repaglinide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00281	CcSEcCtD
Repaglinide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00281	CcSEcCtD
Repaglinide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00281	CcSEcCtD
Repaglinide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000506	0.0028	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000498	0.00276	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000498	0.00276	CcSEcCtD
Repaglinide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00276	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000496	0.00275	CcSEcCtD
Repaglinide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000493	0.00273	CcSEcCtD
Repaglinide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000493	0.00273	CcSEcCtD
Repaglinide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00271	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000488	0.0027	CcSEcCtD
Repaglinide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000483	0.00267	CcSEcCtD
Repaglinide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000482	0.00267	CcSEcCtD
Repaglinide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00048	0.00266	CcSEcCtD
Repaglinide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00266	CcSEcCtD
Repaglinide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00265	CcSEcCtD
Repaglinide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000477	0.00264	CcSEcCtD
Repaglinide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000475	0.00263	CcSEcCtD
Repaglinide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00261	CcSEcCtD
Repaglinide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00261	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.0026	CcSEcCtD
Repaglinide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.00258	CcSEcCtD
Repaglinide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000462	0.00256	CcSEcCtD
Repaglinide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.00254	CcSEcCtD
Repaglinide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000458	0.00254	CcSEcCtD
Repaglinide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00253	CcSEcCtD
Repaglinide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00253	CcSEcCtD
Repaglinide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000454	0.00252	CcSEcCtD
Repaglinide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.0025	CcSEcCtD
Repaglinide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.00249	CcSEcCtD
Repaglinide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00045	0.00249	CcSEcCtD
Repaglinide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00249	CcSEcCtD
Repaglinide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.00248	CcSEcCtD
Repaglinide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00247	CcSEcCtD
Repaglinide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00247	CcSEcCtD
Repaglinide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.0024	CcSEcCtD
Repaglinide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00239	CcSEcCtD
Repaglinide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00235	CcSEcCtD
Repaglinide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00235	CcSEcCtD
Repaglinide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000424	0.00235	CcSEcCtD
Repaglinide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.00235	CcSEcCtD
Repaglinide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00231	CcSEcCtD
Repaglinide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00226	CcSEcCtD
Repaglinide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00226	CcSEcCtD
Repaglinide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00222	CcSEcCtD
Repaglinide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00221	CcSEcCtD
Repaglinide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00219	CcSEcCtD
Repaglinide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00219	CcSEcCtD
Repaglinide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000393	0.00218	CcSEcCtD
Repaglinide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00217	CcSEcCtD
Repaglinide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00214	CcSEcCtD
Repaglinide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00213	CcSEcCtD
Repaglinide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.00212	CcSEcCtD
Repaglinide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00206	CcSEcCtD
Repaglinide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00203	CcSEcCtD
Repaglinide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00203	CcSEcCtD
Repaglinide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00201	CcSEcCtD
Repaglinide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00201	CcSEcCtD
Repaglinide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00201	CcSEcCtD
Repaglinide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00201	CcSEcCtD
Repaglinide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.002	CcSEcCtD
Repaglinide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000361	0.002	CcSEcCtD
Repaglinide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00199	CcSEcCtD
Repaglinide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00199	CcSEcCtD
Repaglinide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00197	CcSEcCtD
Repaglinide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00197	CcSEcCtD
Repaglinide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00196	CcSEcCtD
Repaglinide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000351	0.00194	CcSEcCtD
Repaglinide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00193	CcSEcCtD
Repaglinide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00192	CcSEcCtD
Repaglinide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.0019	CcSEcCtD
Repaglinide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.0019	CcSEcCtD
Repaglinide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000343	0.0019	CcSEcCtD
Repaglinide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.0019	CcSEcCtD
Repaglinide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00189	CcSEcCtD
Repaglinide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00186	CcSEcCtD
Repaglinide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00033	0.00183	CcSEcCtD
Repaglinide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00179	CcSEcCtD
Repaglinide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.00173	CcSEcCtD
Repaglinide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.00173	CcSEcCtD
Repaglinide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000303	0.00453	CbGpPWpGaD
Repaglinide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00165	CcSEcCtD
Repaglinide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000291	0.00435	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000289	0.00432	CbGpPWpGaD
Repaglinide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000289	0.0016	CcSEcCtD
Repaglinide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00158	CcSEcCtD
Repaglinide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00156	CcSEcCtD
Repaglinide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00155	CcSEcCtD
Repaglinide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00154	CcSEcCtD
Repaglinide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00154	CcSEcCtD
Repaglinide—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000277	0.00414	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000276	0.00413	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000276	0.00412	CbGpPWpGaD
Repaglinide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000275	0.00412	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00027	0.00403	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000269	0.00402	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000267	0.00399	CbGpPWpGaD
Repaglinide—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000266	0.00398	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000264	0.00395	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000261	0.0039	CbGpPWpGaD
Repaglinide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000253	0.00379	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00025	0.00375	CbGpPWpGaD
Repaglinide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00137	CcSEcCtD
Repaglinide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.00364	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000242	0.00362	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00024	0.00359	CbGpPWpGaD
Repaglinide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00133	CcSEcCtD
Repaglinide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00131	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000235	0.0013	CcSEcCtD
Repaglinide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00128	CcSEcCtD
Repaglinide—PPARG—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00023	0.00344	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000229	0.00343	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000229	0.00342	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000228	0.00341	CbGpPWpGaD
Repaglinide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00126	CcSEcCtD
Repaglinide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00126	CcSEcCtD
Repaglinide—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.00339	CbGpPWpGaD
Repaglinide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00022	0.00122	CcSEcCtD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.00327	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000217	0.00325	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000214	0.0032	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000209	0.00313	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00115	CcSEcCtD
Repaglinide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00113	CcSEcCtD
Repaglinide—KCNJ11—Metabolism—APIP—chronic obstructive pulmonary disease	0.000203	0.00304	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000202	0.00303	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000201	0.00301	CbGpPWpGaD
Repaglinide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00111	CcSEcCtD
Repaglinide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00109	CcSEcCtD
Repaglinide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00109	CcSEcCtD
Repaglinide—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000197	0.00294	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00293	CbGpPWpGaD
Repaglinide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00108	CcSEcCtD
Repaglinide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00108	CcSEcCtD
Repaglinide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.00289	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00103	CcSEcCtD
Repaglinide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00103	CcSEcCtD
Repaglinide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000999	CcSEcCtD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00269	CbGpPWpGaD
Repaglinide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000994	CcSEcCtD
Repaglinide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00268	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000177	0.00264	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000171	0.00256	CbGpPWpGaD
Repaglinide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000927	CcSEcCtD
Repaglinide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00089	CcSEcCtD
Repaglinide—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00016	0.00239	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000159	0.00238	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00238	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000158	0.00236	CbGpPWpGaD
Repaglinide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00086	CcSEcCtD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—chronic obstructive pulmonary disease	0.000154	0.0023	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000152	0.00228	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000151	0.00226	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APIP—chronic obstructive pulmonary disease	0.00015	0.00224	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000148	0.00221	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00216	CbGpPWpGaD
Repaglinide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000144	0.0008	CcSEcCtD
Repaglinide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000793	CcSEcCtD
Repaglinide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000792	CcSEcCtD
Repaglinide—PPARG—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000143	0.00214	CbGpPWpGaD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00214	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000142	0.00213	CbGpPWpGaD
Repaglinide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000788	CcSEcCtD
Repaglinide—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00014	0.00209	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000139	0.00207	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000138	0.00207	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GC—chronic obstructive pulmonary disease	0.000135	0.00202	CbGpPWpGaD
Repaglinide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000747	CcSEcCtD
Repaglinide—KCNJ11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000134	0.00201	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000133	0.00199	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GC—chronic obstructive pulmonary disease	0.000131	0.00196	CbGpPWpGaD
Repaglinide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00195	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000127	0.0019	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000127	0.0019	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000126	0.00189	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000125	0.00188	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000123	0.00184	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000123	0.00184	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000123	0.00184	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000122	0.00182	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000118	0.00177	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00176	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.00174	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00171	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000112	0.00168	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000112	0.00168	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00011	0.00165	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000108	0.00161	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000107	0.0016	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000107	0.00159	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000105	0.00158	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00157	CbGpPWpGaD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00155	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.0001	0.0015	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.0001	0.0015	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	9.98e-05	0.00149	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.93e-05	0.00149	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.85e-05	0.00147	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.82e-05	0.00147	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.76e-05	0.00146	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.76e-05	0.00146	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.68e-05	0.00145	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GC—chronic obstructive pulmonary disease	9.66e-05	0.00145	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.55e-05	0.00143	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—chronic obstructive pulmonary disease	9.36e-05	0.0014	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.98e-05	0.00134	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	8.9e-05	0.00133	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.9e-05	0.00133	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.78e-05	0.00131	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.52e-05	0.00128	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.43e-05	0.00126	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.42e-05	0.00126	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.32e-05	0.00124	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.93e-05	0.00119	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.82e-05	0.00117	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.76e-05	0.00116	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	7.61e-05	0.00114	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	7.56e-05	0.00113	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.5e-05	0.00112	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.41e-05	0.00111	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.37e-05	0.0011	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	7.28e-05	0.00109	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	7.25e-05	0.00108	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	7.25e-05	0.00108	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	7.19e-05	0.00108	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.17e-05	0.00107	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.16e-05	0.00107	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.14e-05	0.00107	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.07e-05	0.00106	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	7.06e-05	0.00106	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.96e-05	0.00104	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	6.9e-05	0.00103	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.79e-05	0.00102	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	6.75e-05	0.00101	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	6.65e-05	0.000995	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	6.64e-05	0.000994	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.46e-05	0.000966	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	6.44e-05	0.000964	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	6.39e-05	0.000956	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	6.34e-05	0.000948	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	6.33e-05	0.000947	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.23e-05	0.000932	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.15e-05	0.000919	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.12e-05	0.000916	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.12e-05	0.000916	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.07e-05	0.000908	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.94e-05	0.000888	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.85e-05	0.000875	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	5.82e-05	0.000871	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.8e-05	0.000868	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.76e-05	0.000861	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.71e-05	0.000854	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.000843	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	5.49e-05	0.000821	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.33e-05	0.000798	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.28e-05	0.00079	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	5.22e-05	0.000781	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.2e-05	0.000778	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.13e-05	0.000767	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.11e-05	0.000764	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.04e-05	0.000753	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.95e-05	0.000741	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.92e-05	0.000737	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.88e-05	0.000731	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.87e-05	0.000728	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.84e-05	0.000724	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.81e-05	0.00072	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.78e-05	0.000715	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	4.76e-05	0.000712	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.71e-05	0.000705	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.69e-05	0.000702	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.67e-05	0.000699	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.64e-05	0.000695	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.55e-05	0.000681	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.53e-05	0.000677	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.5e-05	0.000673	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.47e-05	0.000669	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.47e-05	0.000668	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.46e-05	0.000667	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.45e-05	0.000666	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	4.44e-05	0.000664	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.43e-05	0.000663	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.39e-05	0.000656	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.37e-05	0.000654	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GC—chronic obstructive pulmonary disease	4.35e-05	0.00065	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.000645	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.18e-05	0.000626	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.16e-05	0.000622	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.11e-05	0.000615	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.07e-05	0.000608	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.04e-05	0.000605	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.83e-05	0.000573	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.75e-05	0.000562	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.75e-05	0.000561	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.66e-05	0.000547	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.64e-05	0.000545	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.64e-05	0.000545	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.61e-05	0.00054	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.47e-05	0.000519	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.45e-05	0.000517	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.45e-05	0.000516	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.38e-05	0.000506	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.36e-05	0.000503	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.24e-05	0.000485	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.22e-05	0.000482	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.22e-05	0.000481	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.21e-05	0.000481	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.000477	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.17e-05	0.000475	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.11e-05	0.000466	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	3.02e-05	0.000452	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.95e-05	0.000441	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	2.93e-05	0.000439	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.89e-05	0.000433	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.88e-05	0.000431	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.86e-05	0.000428	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.84e-05	0.000425	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	2.8e-05	0.00042	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.79e-05	0.000418	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.65e-05	0.000396	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000389	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.51e-05	0.000376	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.41e-05	0.000361	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.41e-05	0.00036	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.39e-05	0.000357	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.38e-05	0.000355	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.36e-05	0.000353	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.000351	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.35e-05	0.000351	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.3e-05	0.000344	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.2e-05	0.000329	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.18e-05	0.000326	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	2.17e-05	0.000324	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000322	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000321	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-05	0.00031	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.99e-05	0.000297	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000295	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.71e-05	0.000255	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.66e-05	0.000248	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.66e-05	0.000248	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000246	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.63e-05	0.000244	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.63e-05	0.000244	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000243	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.52e-05	0.000228	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.52e-05	0.000228	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000226	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000216	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000215	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000192	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.00019	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.25e-05	0.000187	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000173	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000159	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.81e-06	0.000147	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.38e-06	0.00014	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	9.33e-06	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.89e-06	0.000133	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.77e-06	0.000131	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.17e-06	0.000122	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.74e-06	0.000116	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.26e-06	7.87e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.03e-06	7.53e-05	CbGpPWpGaD
